Rao Srinivas — SEC insider filings

SEC reporting owner CIK 1860902. 12 insider filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-06-24 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ATAI Life Sciences N.V. (ATAI)See Remarks101 leg · 3,500 sh · $52,5002 legs · 137,058 sh · $215,84819
AtaiBeckley Inc. (ATAI)See remarks, Director2——13

Insider filings — Rao Srinivas

FiledFormIssuerReported transactionsSource
2026-09-114AtaiBeckley Inc. (ATAI)Disposition to issuer (D): 212,942 · Disposition to issuer (D): 3,500 · Disposition to issuer (D): 650,795 (derivative) · Disposition to issuer (D): 217,778 (derivative) · Disposition to issuer (D): 2,147,408 (derivative) · Disposition to issuer (D): 777,400 (derivative) · +5 moreEDGAR
2026-02-034AtaiBeckley Inc. (ATAI)Grant/award (A): 1,988,000 (derivative) @ $0 · Grant/award (A): 442,000 (derivative) @ $0EDGAR
2025-08-154ATAI Life Sciences N.V. (ATAI)Grant/award (A): 650,794 (derivative) @ $0 · Grant/award (A): 217,777 (derivative) @ $0EDGAR
2025-03-244ATAI Life Sciences N.V. (ATAI)Sale (S): 75,418 @ $1.35EDGAR
2025-03-194ATAI Life Sciences N.V. (ATAI)Option exercise (M): 175,000 · Option exercise (M): 175,000 (derivative) @ $0EDGAR
2025-01-104ATAI Life Sciences N.V. (ATAI)Grant/award (A): 2,340,000 (derivative) @ $0EDGAR
2024-10-044ATAI Life Sciences N.V. (ATAI)Disposition to issuer (D): 1,307,408 (derivative) · Disposition to issuer (D): 840,000 (derivative) · Disposition to issuer (D): 709,952 (derivative) · Grant/award (A): 1,307,408 (derivative) · Grant/award (A): 840,000 (derivative) · Grant/award (A): 709,952 (derivative)EDGAR
2024-04-044ATAI Life Sciences N.V. (ATAI)Sale (S): 61,640 @ $1.85EDGAR
2024-03-154ATAI Life Sciences N.V. (ATAI)Option exercise (M): 175,000 · Grant/award (A): 800,000 (derivative) @ $0 · Option exercise (M): 175,000 (derivative) @ $0EDGAR
2023-03-164ATAI Life Sciences N.V. (ATAI)Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 350,000 (derivative) @ $0EDGAR
2022-03-044ATAI Life Sciences N.V. (ATAI)Grant/award (A): 1,307,408 (derivative) @ $0 · Grant/award (A): 840,000 (derivative) @ $0 · Grant/award (A): 519,240 (derivative) @ $0EDGAR
2021-06-244ATAI Life Sciences N.V. (ATAI)Purchase (P): 3,500 @ $15EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-06-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1860902 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs